Twist Bioscience Corporation (TWST) Stock Analysis & Winston Score

Twist Bioscience makes synthetic DNA — strands of genetic code built from scratch in a lab. Scientists, pharmaceutical companies, and agricultural researchers buy this DNA to develop new medicines, study diseases, and engineer crops. Twist is known for its silicon-based DNA synthesis platform, which lets it produce DNA faster and more cheaply than older methods. The company sells its synthetic DNA products directly to research labs, biotech firms, and government agencies, primarily in North America and Europe. With a gross margin around 52%, Twist earns money on each DNA order, but it still spends heavily on research and operations, resulting in significant losses. Its core competitive advantage is its proprietary manufacturing technology, which allows it to pack far more DNA synthesis reactions onto a chip than traditional methods. The main risk is that Twist must keep growing revenue fast enough to eventually cover its operating costs, and competition from other DNA synthesis companies could pressure pricing over time.